Literature DB >> 6263980

Increased superoxide generation by normal granulocytes incubated in sera from patients with psoriasis.

J B Sedgwick, P R Bergstresser, E R Hurd.   

Abstract

Sera from patients with untreated psoriasis were found to induce increased superoxide anion (O-2) generation when incubated with normal granulocytes (PMNs) and zymosan. Sera from patients receiving systemic chemotherapy induced O-2 generation which was similar to that of normal sera and significantly lower than sera from the untreated patients. O-2 production was measured by superoxide dismutase inhibitable ferricytochrome C reduction and was dependent on the presence of both zymosan and a heat labile serum factor. Serum C3c and C5 levels were elevated in both treated and untreated groups of psoriasis patients while C4 was elevated only in untreated patients. serum ceruloplasmin, a O-2 scavenger, was not decreased in patients with psoriasis, and consequently does not account for the increased O-2 generation. These data suggest that sera from patients with psoriasis have an increased capacity to activate PMNs. Activation of PMNs in cutaneous and joint lesions may play a pathogenic role in psoriasis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263980     DOI: 10.1111/1523-1747.ep12525562

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  15 in total

1.  Neutrophil functions and IL-8 in psoriatic arthritis and in cutaneous psoriasis.

Authors:  D Biasi; A Carletto; P Caramaschi; P Bellavite; T Maleknia; C Scambi; N Favalli; L M Bambara
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

2.  Leukopheresis for treatment of psoriasis: is therapeutical benefit related to reduced activities of neutral proteinases of polymorphonuclear leukocytes?

Authors:  W Gliński; D Barszcz; S Jabłońska; Z Zarebska; M Tigałonowa; E Janczura
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Circulating immune complexes in untreated psoriasis. A comparison of Raji-cell radioimmunoassay and polymorphonuclear leukocyte phagocytosis.

Authors:  L Lindholm; H Mobacken; B L Magnusson
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

4.  Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare.

Authors:  D Barszcz; Z Zarebska; M Glińska-Ferenz; S Jabłońska; M Tigałonowa; W Gliński
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

5.  Decreased extracellular release of granule enzymes from in vitro-stimulated polymorphonuclear leukocytes in guttate psoriasis.

Authors:  W Glinski; M Tigalonowa; S Jablonska; E Janczura
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

6.  Enhanced chemiluminescence production by phagocytosing neutrophils in psoriasis.

Authors:  F J Bloomfield; M M Young
Journal:  Inflammation       Date:  1988-04       Impact factor: 4.092

7.  Increased rate of opsonization of zymosan by serum from patients with psoriasis.

Authors:  T Herlin; N Borregaard
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

8.  Activity of some lysosomal enzyme in rheumatoid and psoriatic arthritis.

Authors:  D Mikulíková; M Stancíková; K Trnavský; F Vlcek
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

9.  Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.

Authors:  A Lundin; L Håkansson; G Michaëlsson; P Venge
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

10.  Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes.

Authors:  Y Miyachi; Y Niwa
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.